Vogel, C L <br/><br/>
Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.  [electronic resource] 

 -  Cancer chemotherapy reports  Apr 1971 
 - 143-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0069-0112 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Imidazoles--administration & dosage<br/>Injections, Intravenous<br/>Leukopenia--chemically induced<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Mouth Neoplasms--drug therapy<br/>Thigh<br/>Thrombocytopenia--chemically induced<br/>Time Factors<br/>Uganda